FDA Approves First PARP Inhibitor for Early BRCA+ Breast Cancer FDA Approves First PARP Inhibitor for Early BRCA+ Breast Cancer
Overall survival results showing a 32% reduction in mortality with olaparib vs placebo will be presented at an upcoming EMSO virtual plenary session.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

As Predicted: Jump in Metastatic Prostate Cancer Diagnoses As Predicted: Jump in Metastatic Prostate Cancer Diagnoses
There was a more than 40% leap in incidence after the USPSTF recommended against routine screening in healthy men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rare Pediatric Cancers Persist 63 Years After Nuclear Accident Rare Pediatric Cancers Persist 63 Years After Nuclear Accident
Covered up for decades, the partial meltdown of a nuclear reactor near Los Angeles in 1959 has had devastating consequences for families living nearby.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pertuzumab-Trastuzumab Combo Ups Infusion Reaction Risk in BCa Pertuzumab-Trastuzumab Combo Ups Infusion Reaction Risk in BCa
The risk of infusion reaction goes up in those with higher baseline lymphocyte counts. The study covered in this summary was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Approves Rika System, a Novel Plasma Collection Device FDA Approves Rika System, a Novel Plasma Collection Device
The Rika system is designed to more quickly, safely, and comfortably collect plasma to meet the growing demand for human plasma-based therapies.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Sotorasib Shows Benefit in Certain Pancreatic Cancers Sotorasib Shows Benefit in Certain Pancreatic Cancers
Sotorasib, approved for lung cancer, has demonstrated clinically meaningful anticancer activity and tolerability in patients with heavily pretreated KRASG12C-mutated advanced pancreatic cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Chemo and RT Before Surgery Boosts Pancreatic Cancer Survival Chemo and RT Before Surgery Boosts Pancreatic Cancer Survival
Long-term results from the Dutch PREOPANC trial confirm that neoadjuvant chemoradiotherapy conveys a survival advantage to patients with resectable and borderline resectable pancreatic cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Many Cancer Centers May Not Be Following PSA Screening Advice Many Cancer Centers May Not Be Following PSA Screening Advice
Contrary to national guidelines, more than a quarter of US cancer centers do not recommend shared decision-making before initiating PSA screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Filling Opioid Prescriptions Akin to a Sisyphean Task Filling Opioid Prescriptions Akin to a Sisyphean Task
In the regulatory environment of the opioid epidemic, getting opioid prescriptions filled in a timely manner with the clinician ' s drug of choice can feel like a Sisyphean task.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

MRI Could Reduce Breast Cancer Deaths in Women at High Risk MRI Could Reduce Breast Cancer Deaths in Women at High Risk
In women genetically at high risk for breast cancer, annual MRI screening at age 30 or 35, followed by concomitant MRI and mammography at age 40, could significantly reduce breast cancer mortality.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Heavy Drinking in Your 20s Has Lasting Impact on Cancer Risk Heavy Drinking in Your 20s Has Lasting Impact on Cancer Risk
A new study suggests that drinking trajectories across the lifespan matter and limiting intake during early adulthood is important for cancer prevention later in life.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Height an ‘Overlooked Risk Factor’ for Colorectal Cancer? Height an ‘Overlooked Risk Factor’ for Colorectal Cancer?
Building on previous evidence, a new study finds that taller people may be more likely to develop colorectal cancer or colon polyps.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Three Trials From ASCO GI Renew Hope Three Trials From ASCO GI Renew Hope
KRYSTAL-1, TOPAZ, and HIMALAYA are more than just catchy trial acronyms, says Dr Mark Lewis.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Colorectal Cancer Trials Enrolling: Could Your Patients Benefit? Colorectal Cancer Trials Enrolling: Could Your Patients Benefit?
Several clinical trials in colorectal cancer have recently started enrolling. Maybe one of your patients could benefit?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncology Groups Support Ukraine, One Cuts Ties With Russian Docs Oncology Groups Support Ukraine, One Cuts Ties With Russian Docs
Major cancer organizations have declared their support for Ukraine, but one group has also severed ties with doctors in Russia, igniting comments about violating the Hippocratic oath.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news